AUTUMN PEFLEY: Open Payments
NPI 1326728239 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 22 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $221 · 2025 $563
Food & beverage: $464Education: $99
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 7 | $179 |
| Astellas Pharma US Inc | 4 | $166 |
| Supernus Pharmaceuticals, Inc. | 3 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| Exeltis, USA Inc. | 2 | $42 |
| Organon LLC | 2 | $32 |
| ABBVIE INC. | 1 | $15 |
Products named: ZURZUVAE, Qelbree, Veozah, SLYND, Mirena, NEXPLANON, Lynkuet, LILETTA.
Industry payments across MD — which companies pay providers there.
